Embryonic Gene Expression During Diabetic Embryopathy

糖尿病胚胎病期间的胚胎基因表达

• 批准号: 8442927
• 负责人: MARY R LOEKEN
• 金额: $ 34.63万
• 依托单位: JOSLIN DIABETES CENTER
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-09-01 至 2015-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8442927
• 关键词: 5' -AMP-activated protein kinase; ATP Citrate (pro-S)-Lyase; Acetyl Coenzyme A; Acetylation; Aerobic; Affect; Antimycin A; Antioxidants; Binding; Biochemical; Biochemical Process; Cardiac; Cell Culture Techniques; Cell Respiration; Cells; Chromatin; Chromatin Structure; Citrates; Complex; Congenital Abnormality; CpG Islands; DNA Methylation; DNA Modification Process; DNA-Binding Proteins; Deacetylase; Defect; Development; Developmental Process; Diabetes Mellitus; Diabetic mother; Diabetic mouse; Differentiated Gene; Electron Transport Complex III; Embryo; Embryonic Development; Epigenetic Process; Failure; Free Radicals; Gene Expression; Genes; Genetic Transcription; Glucose; Heterogeneity; Histone Acetylation; Histone H3; Histones; Human; Hyperglycemia; Hypoxia; Knowledge; Lead; Link; Mediating; Mediator of activation protein; Metabolic; Metabolism; Methylation; Mitochondria; Modification; Molecular; Mothers; Mus; Neural Crest; Neural Tube Defects; Neural tube; Neurons; Organogenesis; Oxidation-Reduction; Oxidative Stress; Pathway interactions; Pattern; Pharmaceutical Preparations; Pregnancy; Procedures; Process; Production; RNA Interference; Reduced Glutathione; Regulation; Regulatory Element; Risk; Sampling; Signal Transduction; Source; Superoxides; Testing; Tissues; Transcription Initiation Site; Undifferentiated; Woman; base; cell type; chromatin modification; diabetic; diabetic embryopathy; embryo cell; embryonic stem cell; glucose metabolism; human embryonic stem cell; in vitro Model; in vivo Model; inhibitor/antagonist; innovation; malformation; maternal diabetes; neuroepithelium; non-diabetic; offspring; oxidation; prevent; research study; response

DESCRIPTION (provided by applicant): Congenital malformations are significantly increased in the offspring of women with pregestational diabetes. Oxidative stress, resulting from excessive glucose metabolism by the embryo, early during embryonic development, is responsible for these malformations. We have shown that oxidative stress inhibits expression of genes in the embryo that control essential developmental processes. In particular, expression of Pax3, which is required for neural tube and neural crest development, is significantly reduced in embryos of diabetic mice, and antioxidants block the inhibition of Pax3 as well as the associated neural tube and neural crest defects. While several of the biochemical processes leading to oxidative stress in embryos of diabetic mothers have been determined, it is not known how oxidative stress disrupts embryo gene expression. The central hypothesis in this proposal is that epigenetic regulation of Pax3 that is associated with increasing aerobic metabolism during early embryonic development is abrogated by oxidative stress resulting from maternal hyperglycemia. This hypothesis is based upon the recognition that fuel metabolism by the early embryo is highly glycolytic and becomes more oxidative as cells differentiate, and that genes that are expressed in the early embryo are dependent upon chromatin modifications. There are three Specific Aims: (1) Test whether oxidative stress blocks epigenetic modifications of the Pax3 transcription regulatory element that are necessary for differentiation-induced gene expression. (2) Test whether mediators of chromatin modifications, which are responsive to changes in oxidation or cellular redox status, change with differentiation, whether they are inhibited by oxidative stress, and whether they regulate Pax3 expression. (3) Test whether AMP-activated protein kinase (AMPK), which is activated in embryos and embryonic stem cells (ESC) in response to hypoxia and oxidative stress, mediates the effects of oxidative stress to block differentiation- induced chromatin modifications. Our approach is to study histone methylation and acetylation and DNA methylation in ESC, and Pax3 expression in mouse embryos and in ESC. ESC will be induced to differentiate into neuronal precursors, and oxidative stress will be induced in ESC or embryos, and the effects of stimulating or inhibiting pathways that potentially modify chromatin in response to oxidative stress will be examined. The proposed study is significant because it will determine the mechanisms by which abnormal fuel metabolism caused by maternal diabetes disrupts the activation of embryonic gene expression, thereby leading to malformations. This knowledge may lead to new strategies to normalize embryo gene expression during diabetic pregnancy. This proposal is innovative because the concept that early embryonic gene expression is developmentally regulated by signals generated by fuel metabolism that alter chromatin structure has not previously been investigated.

描述(由申请人提供)：患有妊娠期糖尿病的妇女的后代中先天畸形显著增加。在胚胎发育早期，由胚胎过度葡萄糖代谢引起的氧化应激是导致这些畸形的原因。我们已经证明，氧化应激抑制胚胎中控制必要发育过程的基因的表达。特别是，在糖尿病小鼠胚胎中，神经管和神经脊发育所需的Pax3的表达显著减少，抗氧化剂阻断了Pax3的抑制以及相关的神经管和神经脊缺陷。虽然已经确定了导致糖尿病母亲胚胎氧化应激的几个生化过程，但氧化应激如何扰乱胚胎基因表达尚不清楚。这一建议的中心假设是，与早期胚胎发育期间有氧代谢增加相关的Pax3的表观遗传调节被母体高血糖引起的氧化应激所废除。这一假说是基于这样的认识，即早期胚胎的燃料代谢是高度糖酵解的，随着细胞的分化变得更加氧化，并且在早期胚胎中表达的基因依赖于染色质的修饰。有三个特定的目的：(1)测试氧化应激是否阻止Pax3转录调控元件的表观遗传修饰，这是分化诱导基因表达所必需的。(2)检测对氧化或细胞氧化还原状态变化作出反应的染色质修饰的介质是否随着分化而改变，它们是否被氧化应激抑制，以及它们是否调节Pax3的表达。(3)检测AMP激活的蛋白激酶(AMPK)在胚胎和胚胎干细胞(ESC)对低氧和氧化应激的反应中是否介导氧化应激以阻断分化诱导的染色质修饰。我们的方法是研究ESC中组蛋白甲基化和乙酰化以及DNA甲基化，以及Pax3在小鼠胚胎和ESC中的表达。ESC将被诱导分化为神经元前体，在ESC或胚胎中将被诱导氧化应激，并将检测潜在地改变染色质以响应氧化应激的刺激或抑制途径的效果。这项拟议的研究意义重大，因为它将确定母体糖尿病引起的燃料代谢异常扰乱胚胎基因表达激活，从而导致畸形的机制。这一知识可能会导致糖尿病妊娠期间胚胎基因表达正常化的新策略。这一建议是创新的，因为早期胚胎基因表达是由燃料代谢产生的改变染色质结构的信号来调节发育的这一概念以前还没有被研究过。